NCT07537465

Brief Summary

The goal of this clinical study is to evaluate the effectiveness of mirror therapy in treating complex regional pain syndrome (CRPS) in patients after stroke using clinical assessments, electrophysiological evaluations, and ultrasonographic measurements by comparing pre- and post-treatment outcomes. The main questions it aims to answer are: Does mirror therapy lead to improvements in clinical outcomes in post-stroke patients with CRPS when assessed before and after treatment? Does mirror therapy reduce pain, improve motor function, and enhance functional independence based on clinical assessments? Does mirror therapy reduce swelling (edema) in the affected limb as measured by ultrasonographic evaluations? Does mirror therapy lead to changes in sympathetic nervous system function as assessed by electrophysiological evaluations? Researchers will compare mirror therapy to sham mirror therapy (a similar procedure without therapeutic effect) to determine its effectiveness. Participants will: Be randomly assigned to either a mirror therapy group or a control group Receive conventional rehabilitation therapy and contrast bath treatment for 4 weeks Receive either mirror therapy or sham mirror therapy for 20 minutes daily Be evaluated before and after treatment using clinical scales, electrophysiological tests, and ultrasonographic measurements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2023

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

April 10, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 10, 2026

Last Update Submit

April 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity (Visual Analog Scale - VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS) before and after the 4-week treatment period.

    Baseline and after 4 weeks

Secondary Outcomes (9)

  • Change in motor recovery (Brunnstrom Staging)

    Baseline and after 4 weeks

  • Change in upper extremity motor function (Fugl-Meyer Assessment)

    Baseline and after 4 weeks

  • Change in spasticity (Modified Ashworth Scale, MAS)

    Baseline and after 4 weeks

  • Change in functional independence (Functional Independence Measure, FIM)

    Baseline and after 4 weeks

  • Change in neuropathic pain (DN4)

    Baseline and after 4 weeks

  • +4 more secondary outcomes

Study Arms (2)

Mirror Therapy Group

EXPERIMENTAL

Participants in this arm received conventional rehabilitation therapy and contrast bath therapy for 4 weeks in addition to mirror therapy for 20 minutes daily

Behavioral: Mirror Therapy

Sham Mirror Therapy Group

SHAM COMPARATOR

Participants in this arm received conventional rehabilitation therapy and contrast bath therapy for 4 weeks in addition to sham mirror therapy for 20 minutes daily

Behavioral: Sham Mirror Therapy

Interventions

Mirror TherapyBEHAVIORAL

Mirror therapy was applied for 20 minutes daily for 4 weeks in addition to a conventional rehabilitation program and contrast bath therapy. Patients performed movements of the unaffected upper limb while watching its reflection in a mirror positioned in the mid-sagittal plane, creating the illusion of movement in the affected limb.

Mirror Therapy Group

Sham mirror therapy was applied for 20 minutes daily for 4 weeks in addition to a conventional rehabilitation program and contrast bath therapy. The non-reflective side of the mirror was used so that no visual feedback of the affected limb was provided, and patients performed similar movements without the mirror illusion.

Sham Mirror Therapy Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a first-ever ischemic or hemorrhagic stroke
  • Time since stroke onset of ≤ 12 months
  • Diagnosed with Complex Regional Pain Syndrome (CRPS) Type 1 according to the Budapest criteria
  • In the dystrophic stage (Stage 2) of CRPS
  • Mini-Mental State Examination (MMSE) score \> 24
  • Brunnstrom upper extremity-hand stage between 1 and 4
  • Age between 18 and 65 years

You may not qualify if:

  • Unstable medical condition
  • Presence of neglect
  • Severe aphasia preventing completion of assessment scales
  • Presence of a concomitant lower motor neuron lesion
  • History of fracture, surgery, or amputation in the affected limb
  • Presence of implanted electronic devices (e.g., cardiac pacemaker)
  • Local infection at the application site
  • Use of oral steroids or pregabalin/gabapentin within the last 3 months
  • History of intra-articular injection, botulinum toxin injection, or suprascapular nerve block within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Başakşehir Çam&Sakura City Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

StrokeComplex Regional Pain Syndromes

Interventions

Mirror Movement Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesAutonomic Nervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesRehabilitationTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical Medicine and Rehabilitation Resident

Study Record Dates

First Submitted

April 10, 2026

First Posted

April 17, 2026

Study Start

October 1, 2022

Primary Completion

October 10, 2023

Study Completion

October 15, 2023

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations